Biomarkers for interstitial lung disease

Martin Kolb (Hamilton, Canada)

Source: International Congress 2016 – ME1 Biomarkers for interstitial lung disease
Session: ME1 Biomarkers for interstitial lung disease
Session type: Meet the expert
Number: 1422

PDF journal article, handout or slidesPDF journal article, handout or slidesWebcastSlide presentation

Rating: 4
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Martin Kolb (Hamilton, Canada). Biomarkers for interstitial lung disease. International Congress 2016 – ME1 Biomarkers for interstitial lung disease

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Interstitial lung disease
Source: Eur Respir Rev 2014; 23: 40-54
Year: 2014



Interstitial lung disease
Source: School Course 2012 - Thoracic Imaging
Year: 2012

Interstitial lung disease
Source: Eur Respir Monogr 2014; 66: 218-231
Year: 2014


Interstitial lung disease
Source: International Congress 2019 – State of the art session: Paediatric respiratory diseases
Year: 2019


Interstitial lung disease
Source: Eur Respir Monogr 2019; 83: 173-187
Year: 2019


Interstitial lung disease
Source: ERS Course 2015
Year: 2015



Interstitial lung disease
Source: International Congress 2015 – Interstitial lung disease, pulmonary hypertension, pulmonary embolism and sleep apnoea
Year: 2015



Interstitial lung disease
Source: ERS Course 2018 - Thoracic imaging
Year: 2018


Biomarkers for pulmonary hypertension in interstitial lung disease
Source: Annual Congress 2011 - Pulmonary hypertension in hypoxic lung disease
Year: 2011


Markers of injury and fibrosis in occupational interstitial lung diseases (OILD)
Source: International Congress 2015 – Occupational disease: clinical cases and series
Year: 2015


Does CRP predicts severity of hospitalized patients with diffuse interstitial lung disease?
Source: International Congress 2014 – ILDs 5
Year: 2014

Biomarkers in pulmonary hypertension associated to interstitial lung disease
Source: Annual Congress 2010 - Pulmonary circulation II
Year: 2010

"Cyclophosphamide for the treatment of inflammation driven fibrotic interstitial lung disease"
Source: International Congress 2014 – ILDs: connective tissue disease
Year: 2014

The prognostic factor in patients with myositis-associated interstitial lung disease
Source: International Congress 2014 – ILDs: connective tissue disease
Year: 2014


Lung cancer and interstitial lung disease
Source: International Congress 2018 – State of the art session: Thoracic oncology
Year: 2018


Clinical characteristics of patients with unclassifiable interstitial lung disease
Source: International Congress 2015 – New insights into IIPs
Year: 2015

Nitrofurantoin-induced interstitial lung disease
Source: Annual Congress 2012 - Viral infections and rare respiratory infections
Year: 2012